scholarly journals P16‐63: Efficacy of high‐ versus low‐dose corticosteroid therapy in patients with acute exacerbation of idiopathic interstitial pneumonia: A nationwide observational study

Respirology ◽  
2021 ◽  
Vol 26 (S3) ◽  
pp. 474-475
Critical Care ◽  
2012 ◽  
Vol 16 (1) ◽  
pp. R3 ◽  
Author(s):  
Hey Yun Park ◽  
Gee Young Suh ◽  
Jae-Uk Song ◽  
Hongseok Yoo ◽  
Ik Joon Jo ◽  
...  

Haigan ◽  
2002 ◽  
Vol 42 (6) ◽  
pp. 567-572 ◽  
Author(s):  
Daisuke Okada ◽  
Kiyoshi Koizumi ◽  
Masashi Kawamoto ◽  
Shinobu Henmi ◽  
Kyoji Hirai ◽  
...  

2016 ◽  
Vol 64 (8) ◽  
pp. 476-480 ◽  
Author(s):  
Satoru Kobayashi ◽  
Yoko Karube ◽  
Morimichi Nishihira ◽  
Takashi Inoue ◽  
Osamu Araki ◽  
...  

1996 ◽  
Vol 1 (1) ◽  
pp. 50-57 ◽  
Author(s):  
Robert S. Lester

Background: Systemic corticosteroids, a mainstay of treatment for severe dermatosis, are associated with systemic complications. Adverse effects of corticosteroids to bone represent a significant adverse effect that, is poorly understood and poorly managed. Objectives: The purpose of this article is to educate dermatologists to the current understanding of the pathogenesis, diagnosis, and treatment options available for bone complications of corticosteroids. Results: Virtually all patients chronically exposed to high-dose corticosteroid therapy lose bone mass and are at risk for osteoporotic fractures. In addition, osteonecrosis is an unpredictable complication of corticosteroid therapy that may occur with even low-dose corticosteroids. Conclusion: Optimal risk management of corticosteroid therapy includes understanding the risk factors associated with bone complications and improving communication with patients.


Sign in / Sign up

Export Citation Format

Share Document